AHR and inflammatory bowel disease: The aryl hydrocarbon receptor (AHR) is pivotal in the pathogenesis and treatment of inflammatory bowel disease (IBD) due to its diverse immunomodulatory effects, which include immune regulation, modulation of the gut microbiota, anti-inflammatory actions, and tissue repair [18].